The FDA cited the vaccine plant that ruined millions of Johnson & Johnson doses for unsanitary conditions, finding "brown residue" on the walls and peeling paintBusiness Insider • 04/21/21
House Democrats Investigating Emergent BioSolutions' Vaccine Contracts, Call On Execs To TestifyBenzinga • 04/21/21
EMERGENT BIOSOLUTIONS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Emergent BioSolutions, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 04/21/21
Congressional investigation launched into Emergent BioSolutions' federal vaccine contractsCNBC • 04/20/21
Emergent BioSolutions Stock Falls After FDA Initiates Inspection Of Bayview FacilityBenzinga • 04/19/21
FDA asks Emergent plant to pause manufacturing while it investigates botched Covid vaccinesCNBC • 04/19/21
Emergent BioSolutions says it has agreed with FDA not to manufacture new material at Baltimore facilityMarket Watch • 04/19/21
Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021GlobeNewsWire • 04/15/21
EMERGENT BIOSOLUTIONS ALERT: Bragar Eagel & Squire, P.C. is Investigating Emergent BioSolutions, Inc. on Behalf of Emergent Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 04/13/21
Entwistle & Cappucci LLP Investigative Alert: Emergent BioSolutions Inc. (EBS)Business Wire • 04/08/21
Johnson & Johnson Given Control of Emergent BioSolutions Factory That Botched Its Coronavirus VaccineThe Motley Fool • 04/05/21
Emergent BioSolutions' Plasma-Based Therapy Candidate Flunks COVID-19 Study; HHS Increases Task Order By $23MBenzinga • 04/05/21
Emergent BioSolutions says on track with COVID vaccines, reaffirms guidance after J&J vaccine snafuMarket Watch • 04/05/21
Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments; Receives Modified Task Order from the U.S. Department of Health & Human Services to Support the Opportunity for Further Expansion of Manufacturing Capacity for Johnson & JohnGlobeNewsWire • 04/05/21
US Puts Johnson & Johnson In Charge Of Troubled Vaccine Plant In Baltimore, Removes AstraZenecaBenzinga • 04/04/21
Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19GlobeNewsWire • 04/02/21
Emergent BioSolutions tumbles 7% after J&J says it spoiled 15 million COVID-19 vaccine doses (EBS, JNJ, AZN)Business Insider • 04/01/21